I was at the ASC, and heard the presentation. General consensus was: Yeah, no kidding. Overall, it was striking how "managed" the presentation was. It was as political as it was scientific.
Personally, I think the trial was ambitious and impressive...but ultimately flawed. They got the answer they wanted to get, which is what everyone predicted when the design was announced two years ago. Did anyone really believe that having a few residents (potentially) working more would influence the total mortality and serious morbidity rate by 10%?
The presentation also glossed over the fact that I do believe that it is reasonable to question the ethics surrounding how it was approved. The answer to the criticisms was basically: "Some people have problems, but they're wrong. We have a bioethicist who says we are ok, and no surgery residents complained." First, of course no surgery residents complained. Second, it seems laughable that the IRB determined that the people participating in the trial were the Institutions, and not the residents or patients.
As for what the results will mean, I suspect we will see the rules relaxed. The ACGME rep that was there hinted as much. But as for what the trial means for surgical education, I think Birkmeyer's critique is interesting. Sure the trial could be interpreted to mean that flexible rules are ok. But it can also be interpreted to mean that the restrictive hours are ok too. I think Dr. Hoyt's comments were the most important. This is just a small piece of efforts to determine how surgeons should be trained, and it shouldn't be interpreted to mean that we can simply put people in the hospital for longer periods of time and expect they will be better surgeons. The amount of time is much less important than what is actually done with that time. If the flexible time is used in the OR, managing active patient issues or in educational activities that is great. If it's used to wait 3 hours while a chief/attending gets out of the OR so you can round in the evening it's likely less useful.